SLC16A1 NM_003051.4(SLC16A1):c.973A>G (p.Ile325Val)

CI-VAR-00127340Explore in graph →p.Ile325ValNM_003051.4:c.973A>GClinVar 712920 rs116216229

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
712920	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	2	Metabolic myopathy due to lactate transporter defect; Exercise-induced hyperinsulinism; Ketoacidosis due to monocarboxylate transporter-1 deficiency; SLC16A1-related disorder; Malignant tumor of urinary bladder	germline	7	Jan 27, 2026	clinvar